ArcticZymes Technologies Crecimiento futuro

Future controles de criterios 4/6

Se prevé un crecimiento anual de los beneficios y los ingresos de ArcticZymes Technologies de 34.7% y 15.6% por año respectivamente. Se prevé que el BPA crezca en un 34.6% al año. Se espera que la rentabilidad financiera sea de 12.7% en 3 años.

Información clave

42.2%

Tasa de crecimiento de los beneficios

1.8%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Biotechs	-9.1%
Tasa de crecimiento de los ingresos	16.1%
Rentabilidad financiera futura	8.2%
Cobertura de analistas	Low
Última actualización	10 May 2024

Actualizaciones recientes sobre el crecimiento futuro

ArcticZymes Technologies ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 04

Recent updates

ArcticZymes Technologies' (OB:AZT) Shareholders Have More To Worry About Than Only Soft Earnings

Feb 08

ArcticZymes Technologies ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 04

Investors Aren't Buying ArcticZymes Technologies ASA's (OB:AZT) Revenues

Feb 02

ArcticZymes Technologies ASA's (OB:AZT) Sole Analyst Just Made A Substantial Upgrade To Their Forecasts

Apr 29

Downgrade: Here's How This Analyst Sees ArcticZymes Technologies ASA (OB:AZT) Performing In The Near Term

Apr 15

One Analyst Just Shaved Their ArcticZymes Technologies ASA (OB:AZT) Forecasts Dramatically

Jan 13

Here's What Analysts Are Forecasting For ArcticZymes Technologies ASA (OB:AZT) After Its First-Quarter Results

May 01

What ArcticZymes Technologies ASA's (OB:AZT) P/E Is Not Telling You

Oct 28

A Look At The Fair Value Of ArcticZymes Technologies ASA (OB:AZT)

Jul 26

I Ran A Stock Scan For Earnings Growth And ArcticZymes Technologies (OB:AZT) Passed With Ease

Apr 28

Can You Imagine How Elated ArcticZymes Technologies' (OB:AZT) Shareholders Feel About Its 992% Share Price Gain?

Mar 17

Is Weakness In ArcticZymes Technologies ASA (OB:AZT) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Jan 31

What Percentage Of ArcticZymes Technologies ASA (OB:AZT) Shares Do Insiders Own?

Jan 05

Are ArcticZymes Technologies's (OB:AZT) Statutory Earnings A Good Guide To Its Underlying Profitability?

Dec 01

Previsiones de crecimiento de beneficios e ingresos

OB:AZT - Estimaciones futuras de los analistas y datos financieros pasados (NOK Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	179	43	N/A	N/A	1
12/31/2025	148	24	N/A	N/A	1
12/31/2024	122	12	N/A	N/A	1
3/31/2024	118	17	7	28	N/A
12/31/2023	120	19	5	24	N/A
9/30/2023	119	18	8	28	N/A
6/30/2023	118	14	8	25	N/A
3/31/2023	120	17	20	35	N/A
12/31/2022	138	33	46	58	N/A
9/30/2022	150	47	56	64	N/A
6/30/2022	147	52	58	68	N/A
3/31/2022	139	48	55	65	N/A
12/31/2021	131	46	63	75	N/A
9/30/2021	114	68	54	64	N/A
6/30/2021	108	67	57	61	N/A
3/31/2021	120	84	63	66	N/A
12/31/2020	98	74	45	47	N/A
9/30/2020	64	43	48	50	N/A
6/30/2020	68	37	37	39	N/A
3/31/2020	88	8	10	12	N/A
12/31/2019	49	-1	3	4	N/A
9/30/2019	80	-9	-3	-1	N/A
6/30/2019	79	-10	-11	-9	N/A
3/31/2019	73	-13	-10	-7	N/A
12/31/2018	73	-14	-18	-15	N/A
9/30/2018	70	-20	-25	-22	N/A
6/30/2018	63	-27	-24	-21	N/A
3/31/2018	69	-27	-27	-23	N/A
12/31/2017	73	-25	N/A	-22	N/A
9/30/2017	74	-26	N/A	-23	N/A
6/30/2017	80	-24	N/A	-22	N/A
3/31/2017	79	-21	N/A	-18	N/A
12/31/2016	79	-20	N/A	-19	N/A
9/30/2016	78	-20	N/A	-14	N/A
6/30/2016	72	-19	N/A	-13	N/A
3/31/2016	66	-18	N/A	-14	N/A
12/31/2015	59	-17	N/A	-13	N/A
9/30/2015	55	-15	N/A	-14	N/A
6/30/2015	48	-16	N/A	-17	N/A
3/31/2015	46	-18	N/A	-20	N/A
12/31/2014	38	-22	N/A	-21	N/A
9/30/2014	34	-23	N/A	-23	N/A
6/30/2014	31	-21	N/A	-26	N/A
3/31/2014	26	-24	N/A	-21	N/A
12/31/2013	28	-23	N/A	-17	N/A
9/30/2013	29	-23	N/A	-20	N/A
6/30/2013	26	-25	N/A	-20	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (34.7% al año) de AZT es superior a la tasa de ahorro (2%).

Beneficios vs. Mercado: Se prevé que los beneficios (34.7% al año) de AZT crezcan más rápidamente que el mercado Norwegian (13.3% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de AZT crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (15.6% al año) de AZT crezcan más rápidamente que los del mercado Norwegian (2.3% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 15.6% al año) de AZT crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de AZT sea baja dentro de 3 años (12.7%).

ArcticZymes Technologies Crecimiento futuro

Future controles de criterios 4/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus revenue estimates fall by 14%

ArcticZymes Technologies ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Price target decreased by 8.6% to kr32.00

Consensus EPS estimates increase by 128%

Consensus EPS estimates fall by 57%

Consensus revenue estimates increase by 11%

Recent updates

First quarter 2024 earnings: Revenues in line with analyst expectations

ArcticZymes Technologies ASA Announces Resignation of Edgar Koster as Board Member

ArcticZymes Technologies' (OB:AZT) Shareholders Have More To Worry About Than Only Soft Earnings

Consensus revenue estimates fall by 14%

New major risk - Earnings quality

ArcticZymes Technologies ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Price target decreased by 8.6% to kr32.00

Investors Aren't Buying ArcticZymes Technologies ASA's (OB:AZT) Revenues

Full year 2023 earnings: EPS and revenues miss analyst expectations

Arcticzymes Technologies Asa Announces the Launch of Its First Gmp-Grade Product, San Hq

ArcticZymes Technologies ASA Launches T7 RNA Polymerase

ArcticZymes Technologies ASA, Annual General Meeting, Jun 05, 2024

Consensus EPS estimates increase by 128%

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

ArcticZymes Technologies ASA Announces DMF for SAN HQ GMP accepted by the US FDA

Consensus EPS estimates fall by 57%

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

ArcticZymes Technologies ASA Appoints Michael Akoh as Chief Executive Officer, Will Commence His Position No Later Than 1 November 2023

Chief Financial Officer exercised options and sold kr4.2m worth of stock

First quarter 2023 earnings: EPS and revenues miss analyst expectations

ArcticZymes Technologies ASA's (OB:AZT) Sole Analyst Just Made A Substantial Upgrade To Their Forecasts

Consensus revenue estimates increase by 11%

Consensus revenue estimates increase by 11%

Downgrade: Here's How This Analyst Sees ArcticZymes Technologies ASA (OB:AZT) Performing In The Near Term

Consensus revenue estimates fall by 10%

Consensus EPS estimates fall by 25%

Director recently bought kr426k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Consensus revenue estimates fall by 12%

One Analyst Just Shaved Their ArcticZymes Technologies ASA (OB:AZT) Forecasts Dramatically

Consensus revenue estimates fall by 12%

Investor sentiment deteriorated over the past week

ArcticZymes Technologies Launches SAN HQ 2.0 ELISA kit

ArcticZymes Technologies ASA Appoints Darren Ellis as Chief Scientific Officer

ArcticZymes Technologies ASA to Report Q4, 2022 Results on Feb 02, 2023

Consensus EPS estimates fall by 21%

Consensus EPS estimates fall by 21%

Consensus EPS estimates fall by 21%

Consensus EPS estimates increase by 26%

No independent directors

Consensus forecasts updated

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

ArcticZymes Technologies ASA Announces Resignation of Volker Wedershoven as Board Member

Price target decreased to kr101

Second quarter 2022 earnings released: EPS: kr0.17 (vs kr0.09 in 2Q 2021)

Director recently sold kr169k worth of stock

Here's What Analysts Are Forecasting For ArcticZymes Technologies ASA (OB:AZT) After Its First-Quarter Results

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

No independent directors

ArcticZymes Technologies ASA Provides Sales Guidance for the Year 2022

Full year 2021 earnings: EPS and revenues exceed analyst expectations

ArcticZymes Technologies Launches New Products

Chief Executive Officer exercised options to buy kr18m worth of stock.

Chief Executive Officer recently sold kr11m worth of stock

Third quarter 2021 earnings released: EPS kr0.14 (vs kr0.19 in 3Q 2020)

What ArcticZymes Technologies ASA's (OB:AZT) P/E Is Not Telling You

Second quarter 2021 earnings released: EPS kr0.09 (vs kr0.44 in 2Q 2020)

Investor sentiment deteriorated over the past week

A Look At The Fair Value Of ArcticZymes Technologies ASA (OB:AZT)

ArcticZymes Technologies ASA Launches SAN HQ 2.0

Director recently sold kr1.7m worth of stock

Investor sentiment improved over the past week

I Ran A Stock Scan For Earnings Growth And ArcticZymes Technologies (OB:AZT) Passed With Ease

First quarter 2021 earnings released: EPS kr0.40 (vs kr0.19 in 1Q 2020)

Can You Imagine How Elated ArcticZymes Technologies' (OB:AZT) Shareholders Feel About Its 992% Share Price Gain?

Investor sentiment deteriorated over the past week

New 90-day high: kr82.80

Is Weakness In ArcticZymes Technologies ASA (OB:AZT) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Full year 2020 earnings released: EPS kr1.75 (vs kr0.13 loss in FY 2019)